
According to Arthritis Foundation, over 50 million adults and 300,000 babies and children in the U.S. are inflicted with arthritis or other rheumatic condition. As such, injection technique has been instrumental for diagnosis and therapy in a range of musculoskeletal conditions. These actionable insights are according to the intelligence report titled, "Joint Pain Injections Market—Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026," which has been of late added to Market Research Hub's (MRH) growing repository. Assessing the market revenue, the market for joint pain injections is expected to expand at a CAGR of over 8 percent during the assessment period. The prevalence of psoriatic arthritis which can affect any part of the body and range from mild to severe, disease flares alternate with periods of remission. Given till date there is no cure for psoriatic arthritis, there is heavy focus on containing symptoms and averting damage to the joints. Accordingly, it becomes imperative to opt for joint care treatments. According to the study, North America rules the roost with burgeoning population, soaring obesity and growing acceptance of sophisticated treatments for the joint relief. The approval of viscosupplementation with hyaluronic acid products for treatment of knee osteoarthritis has had positive influence in the joint pain injections market.